register

Digital & Innovation

Immunology company collaborates in bringing advanced AI capacity to point of care

Health Industry Hub | April 7, 2021 |

Digital & Innovation: As a leading provider of artificial intelligence (AI) technology, the Brainchip Research Institute in Perth has entered into a research collaboration with precision immunology company Biotome who are developing next generation antibody diagnostics.

Dr. Samuel Lundin, CEO of Biotome said “We believe the precision of antibody tests for infections can be improved dramatically. Our partnership with Brainchip is an important step for our development of point-of-care tests that are based on patented high-precision immunological markers. We are very excited to explore how the cutting-edge Akida neural processor can improve the accuracy and information quality of the antibody-tests we are developing, by providing advanced AI capacity at the point of care. The joint project we are embarking on aims to use Akida to identify the antibodies that can protect against SARS- CoV-2 infection – the so-called neutralising antibodies. If the project is successful we will apply the same principles to other antibody tests in our pipeline.”

MedTech News - Market access and funding key barriers to MedTech innovation, says President of Stryker Asia-Pacific

The objective of the Biotome research project is to create a handheld device that uses nanomaterial-based sensors in combination with the Akida chip that will give accurate results in seconds.

Peter van der Made, Interim CEO of BrainChip, said “The use of the Akida neuromorphic processor in antibody detection and other medical diagnostic tools is a testimony to our efforts to help in the development of beneficial Artificial Intelligence applications around our chip. Our focus is the Akida neuromorphic processor, and we are a silicon manufacturer, but we are assisting our clients in bringing advanced AI products to market”.

The Akida processor is an essential part of this development in its ability to learn new sensory data patterns instantly, and classify the results in milliseconds at a power consumption in the microwatts range. This enables the use of advanced diagnostic equipment that operates on small batteries in even remote locations.

BrainChip’s Akida chip brings artificial intelligence to the edge in a way that existing technologies are not capable. The solution is high-performance, small, ultra-low power and provides a wide array of capabilities. The Akida (NSoC) and intellectual property, can be used in applications including Smart Home, Smart Health, Smart City and Smart Transportation.

These applications include but are not limited to home automation and remote controls, industrial IoT, robotics, security cameras, sensors, unmanned aircraft, autonomous vehicles, medical instruments, object detection, sound detection, odour and taste detection, gesture control and cybersecurity. The Akida NSoC is designed for use as a stand-alone embedded processor or as a co-processor, and includes interfaces for ADAS sensors, audio and video sensors, medical sensors and other IoT sensors.


Digital & Innovation

Medical drone to reduce health equity gaps in rural and remote Australia

Medical drone to reduce health equity gaps in rural and remote Australia

Health Industry Hub | April 24, 2024 |

A specialised medical drone which increases accessibility to essential health services such as pathology, medicines, and telehealth services in rural […]

More


News & Trends - Pharmaceuticals

We’ve spent more on healthcare, but it’s been worth it

We’ve spent more on healthcare, but it’s been worth it

Health Industry Hub | April 24, 2024 |

Healthcare expenditure is surging, with Australia now allocating approximately one-tenth of its budget to this sector. This financial uptick prompts […]

More


News & Trends - Pharmaceuticals

New partnership to raise the bar in precision cancer care in Queensland

New partnership to raise the bar in precision oncology in Queensland

Health Industry Hub | April 24, 2024 |

Pharma News: The Australian Translational Genomics Centre (ATGC) is teaming up with non-profit research organisation Omico and the PrOSPeCT program […]

More


News & Trends - Biotechnology

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

Health Industry Hub | April 23, 2024 |

Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]

More


This content is copyright protected. Please subscribe to gain access.